Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
Clinical trial NCT03222674 · RECRUITING
Trial details
- NCT number
- NCT03222674
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2028-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.